Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

Intravenous immunoglobulin (IVIg) is a potential alternative treatment for anti-neutrophil cytoplasm antibody (ANCA)-associated systemic vasculitis (AASV) with less toxicity than conventional immunosuppressive agents. This randomized, placebo-controlled trial aimed to investigate the efficacy of a s...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Jayne, DR, Chapel, H, Adu, D, Misbah, S, O'Donoghue, D, Scott, D, Lockwood, C
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2000

Παρόμοια τεκμήρια

Placebo-controlled trial of intravenous immunoglobulin in ANCA-associated systemic vasculitis.
ανά: Jayne, D, κ.ά.
Έκδοση: (1999)

Cardiovascular outcomes in ANCA associated vasculitis
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2008)

Diagnosis and management of ANCA associated vasculitis.
ανά: Berden, A, κ.ά.
Έκδοση: (2012)

Comparison of disease activity measures for ANCA-associated vasculitis.
ανά: Merkel, P, κ.ά.
Έκδοση: (2004)

Explaining fatigue in ANCA-associated vasculitis.
ανά: Basu, N, κ.ά.
Έκδοση: (2013)

Explaining fatigue in ANCA-associated vasculitis
ανά: Basu, N, κ.ά.
Έκδοση: (2013)

Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
ανά: Arnold, D, κ.ά.
Έκδοση: (2010)

ANCA Associated Vasculitis Subtypes: Response [Letter]
ανά: Merkel PA, κ.ά.
Έκδοση: (2022-09-01)

Markers for work disability in ANCA-associated vasculitis
ανά: Basu, N, κ.ά.
Έκδοση: (2013)

Predictors of renal involvement in ANCA associated vasculitis
ανά: Kronbichler, A, κ.ά.
Έκδοση: (2018)

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
ανά: Lapraik, C, κ.ά.
Έκδοση: (2007)

Long-term survival of ANCA-associated vasculitis
ανά: Flossmann, O, κ.ά.
Έκδοση: (2009)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

Cardiovascular disease incidence and risk factors in ANCA-associated primary systemic vasculitis (AASV)
ανά: Salisbury, E, κ.ά.
Έκδοση: (2003)

The characterisation and determinants of quality of life in ANCA associated vasculitis.
ανά: Basu, N, κ.ά.
Έκδοση: (2014)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
ανά: Jones, R, κ.ά.
Έκδοση: (2010)

Intravenous immunoglobulin therapy.
ανά: Chapel, H
Έκδοση: (1996)

CONTEXTUALISING QUALITY OF LIFE IN ANCA ASSOCIATED VASCULITIS (AAV)
ανά: Basu, N, κ.ά.
Έκδοση: (2012)

The characterisation and determinants of quality of life in ANCA associated vasculitis
ανά: Basu, N, κ.ά.
Έκδοση: (2014)

THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
ανά: Yew, S, κ.ά.
Έκδοση: (2012)

Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study
ανά: David Jayne, κ.ά.
Έκδοση: (2024-07-01)

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
ανά: Ntatsaki, E, κ.ά.
Έκδοση: (2014)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
ανά: Luqmani, R, κ.ά.
Έκδοση: (2007)

26 Lessons learned from complement inhibition in ANCA vasculitis
ανά: David Jayne
Έκδοση: (2021-04-01)

CARDIOVASCULAR AND CEREBROVASCULAR DISEASE INCIDENCE AND RISK FACTORS IN ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV)
ανά: Salisbury, E, κ.ά.
Έκδοση: (2004)

Long-term patient survival in ANCA-associated vasculitis
ανά: Flossmann, O, κ.ά.
Έκδοση: (2011)

Long-term patient survival in ANCA-associated vasculitis.
ανά: Flossmann, O, κ.ά.
Έκδοση: (2011)

Interstitial Lung Disease with ANCA-associated Vasculitis
ανά: Yasuhiro Katsumata, κ.ά.
Έκδοση: (2015-01-01)

Updates in ANCA-associated vasculitis
ανά: Carolyn Ross, κ.ά.
Έκδοση: (2022-07-01)

Epidemiology of ANCA associated vasculitis
ανά: Wenche Koldingsnes, κ.ά.
Έκδοση: (2008-01-01)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
ανά: Yew, S, κ.ά.
Έκδοση: (2012)

Long-term patient survival in ANCA-associated vasculitis.
ανά: Flossmann, O, κ.ά.
Έκδοση: (2011)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
ανά: Merkel, P, κ.ά.
Έκδοση: (2009)

Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV).
ανά: Basu, N, κ.ά.
Έκδοση: (2012)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
ανά: Zachary S. Wallace, κ.ά.
Έκδοση: (2019-12-01)

Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.
ανά: Olivier M Lardinois, κ.ά.
Έκδοση: (2019-01-01)

Home intravenous immunoglobulin therapy.
ανά: Chapel, H, κ.ά.
Έκδοση: (1988)

Damage assessment in ANCA-associated vasculitis.
ανά: Bhamra, K, κ.ά.
Έκδοση: (2012)